Loading company…
Polku Therapeutics develops drug candidates for neurodegenerative disorders such as Parkinson’s and Alzheimer’s.
Polku Therapeutics researches therapies for neurodegenerative diseases, focusing on ligands that target the PREP enzyme. Founded in 2023 as a University of Helsinki spinout, it is based in Helsinki, Finland. In August 2024, it raised EUR 2 million in pre-seed funding from Torrey Pines Investment, Innovestor, Business Finland, and Helsinki University Funds.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in